- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about DEA
Recent news which mentions DEA
3 Stocks to Buy Now If You're Anxious About the Stock Market
February 02, 2022
From Motley Fool
3 Dividend Stocks to Buy and Hold Forever
January 23, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2022
January 10, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
22 Top Dividend Stocks to Buy and Hold in 2022
January 02, 2022
From Motley Fool
DEA Should Allow Psilocybin Therapy For Terminally Ill, Says Congressmen Blumenauer, Seeks Lawmakers' Support
December 20, 2021
Tickers
DEA
From Benzinga
Here’s a list of favored dividend stocks with room to pay more for investors worried about 2022
December 10, 2021
From MarketWatch
DEA Raises Production Quota For Psychedelics Like MDMA, Psilocybin and DMT As Research Flourishes
December 02, 2021
Tickers
DEA
From Benzinga
These 3 Dividend Stocks Are Practically Money Machines
November 22, 2021
From Motley Fool
4 Top Dividend Stocks I'd Buy If I Were About to Retire
November 21, 2021
From Motley Fool
Biden's FDA Pick Has Prescribed CBD, Recognizes Potential: Will He Lead Govt Closer To Legalization?
November 15, 2021
Tickers
DEA
From Benzinga
4 Fantastic Dividend Stocks to Buy With Yields of 4% or More
November 14, 2021
From Motley Fool
DEA Raises Production Levels For Psychedelics, Deschedules Cocaine-Derived Drug, Could Cannabis Be Next?
November 12, 2021
Tickers
DEA
From Benzinga
3 Top Small-Cap Stocks to Buy Right Now
November 08, 2021
From Motley Fool
Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income
November 07, 2021
From Motley Fool
Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules
November 04, 2021
From Benzinga
Tickers
DEA
From Motley Fool
3 Least Scary Stocks to Buy Right Now
October 31, 2021
From Motley Fool
Cannabis Legalization Activists Build Monolith In Front Of DEA HQ, Demand Feds Evolve On Antiquated Drug Policy
October 20, 2021
Tickers
DEA
From Benzinga
Illicit Cannabis Farm So Huge, It Was Visible From Space: Earthlings Bungle The Bust, Bury The Evidence
September 27, 2021
Tickers
DEA
From Benzinga
3 Dividend Stocks to Buy If You're Worried About the Stock Market
September 05, 2021
From Motley Fool
The DEA Seeks To Increase Federal Production Limits For Psilocybin And Marijuana Research
September 01, 2021
Tickers
DEA
From Benzinga
Court Dismisses Petition Requiring DEA To Reschedule Cannabis, But One Judge Says It Could Still Be Reclassified
August 31, 2021
Tickers
DEA
From Benzinga
From Benzinga
3 No-Brainer Dividend Stocks to Buy Right Now
August 15, 2021
From Motley Fool
The Current State of Real Estate With Matt Argersinger
August 12, 2021
From Motley Fool
Cannabis Research Turns Up In Bipartisan Infrastructure Bill, Would Allow Scientists To Use Marijuana From Dispensaries
August 04, 2021
From Benzinga
Tickers
DEA
Tickers
DEA
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.